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The adenovirus repression domain of E1A 243R at the E1A N-terminus (E1A 1–80) transcriptionally
represses genes involved in differentiation and cell cycle progression. E1A 1–80 represses transcription
in vitro from naked DNA templates through its interaction with p300 and TFIID. E1A 1–80 can also
interact with several chromatin remodeling factors and associates with chromatin in vivo. We show
here that E1A 243R and E1A 1–80 can repress transcription from a reconstituted chromatin template
in vitro. Temporal analysis reveals strong repression by E1A 1–80 when added at pre-activation,
activation and early transcription stages. Interestingly, E1A 1–80 can greatly enhance transcription
from chromatin templates, but not from naked DNA, when added at pre-initiation complex (PIC)
formation and transcription-initiation stages. These data reveal a new dimension for E1A 1–80’s
interface with chromatin and may reﬂect its interaction with key players in PIC formation, p300 and
TFIID, and/or possibly a role in chromatin remodeling.
& 2012 Elsevier Inc. All rights reserved.Introduction
E1A is the ﬁrst viral gene expressed during productive infection
with human adenoviruses (Ads). E1A encodes multifunctional
proteins that are essential for viral replication, have many interest-
ing properties and profoundly impact cell function. The Ad group C
(types 2 and 5) E1A oncogene encodes two major proteins of 243
and 289 amino acid residues (243R and 289R) which contain
multiple functional domains that interact with a number of impor-
tant cellular regulatory proteins. The diverse functions of E1A
include transcription-activation, induction of cellular DNA synthesis,
cell immortalization, cell transformation, and of particular interest
transcription repression. E1A 289R differs from E1A 243R by
conserved region 3 (CR3), a 46 amino acid domain unique to 289R
that is involved in transcription-activation of Ad early genes. The Ad
E1A 243R oncoprotein encodes two conserved domains and a less
well conserved N-terminus in exon 1 which is essential for cell
immortalization and cell transformation (Rasti et al., 2005). This
region of E1A 243R can induce S-phase DNA synthesis and cell cycle
progression by two pathways: (i) the Rb-E2F pathway which
involves sequences within CR1 (residues 41 to 80) and CR2 (residues
121 to 139) that interact with the Rb family member proteins; and
(ii) the N-terminal pathway within the E1A N-terminal 80 amino
acids (E1A 1–80) consisting of CR1 and less well conserved residues
1 to 40. It is signiﬁcant that the growth regulatory functions of E1All rights reserved.require sequences that reside within E1A 1–80. An important
biochemical function encoded in the E1A N-terminus is the ability
to transcriptionally repress cellular genes involved in cell prolifera-
tion and differentiation. The E1A repression domain takes on added
importance in that it can transcriptionally repress promoters of
clinical signiﬁcance such as the HER2 proto-oncogene (Loewenstein
and Green, 2011).
A major focus of our laboratory is the mechanism of E1A
transcription-repression. Our combined ﬁndings suggest a two-
step model for E1A repression. Brieﬂy, E1A gains access to
repressible promoters by interaction with cellular partners such
as p300 as molecular scaffolds, thereby facilitating contact with
TBP where it can disrupt the basal transcription machinery. This
model of E1A repression is based on a detailed functional-muta-
tional analysis using several experimental approaches including
in vivo microinjection, DNA footprinting, gel mobility shift, DNA
transfection, ChIP (chromatin immunoprecipitation) and extensive
in vitro transcription analysis (Song et al., 1995a,b,c, 2007; Boyd
et al., 2002; Loewenstein et al., 2006, 2007; Green et al., 2008a,b).
The assays used to develop this model of E1A transcription-
repression utilized naked DNA templates to measure transcription
and E1A induced repression of transcription. Transcription from a
naked DNA template occurs at a high basal rate and it can be
argued that E1A’s access to a naked promoter does not accurately
reﬂect the complexity of transcription from the natural chromatin
state. Cellular chromatin is organized into compact repeating units
(nucleosomes) composed of about 146 bp of DNA wrapped around
an octamer of four core histones (Wolffe, 1998). Within the cell,
the structure of chromatin is dynamic which is necessary for the
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E1A interacts with chromatin in adenovirus infected and trans-
formed cells (Green et al., 2008a). It is therefore important to
study E1A repression of transcription from a chromatin template
in order to completely understand its regulation and further deﬁne
the role of p300/CBP and TBP in E1A repression. Further, the use of
chromatin templates may elucidate the possible roles of histone
acetyltransferases (HATs) other than p300/CBP that interact with
the E1A N-terminus including PCAF, hGCN5, TRRAP, p400 and
Tip60 (reviewed in Frisch and Mymryk, 2002). The interaction of
E1A N-terminal sequences with these HATs suggests that the E1A
repression domain may also regulate chromatin remodeling. The
development of in vitro reconstituted chromatin transcription
systems, as described by Thomas and Chiang (2005) to analyze
HPV E6 oncoprotein repression of p53 dependent gene activation,
provides an opportunity to further extend the model of E1A
repression using a more natural chromatin template system.Fig. 1. (A) SDS-PAGE gel of the puriﬁed protein components required for the assembly
and in vitro transcription of chromatin templates. Proteins were puriﬁed as described
in Materials and methods. Aliquots were subjected to SDS-PAGE electrophoresis and
the protein bands stained with SYPRO orange and visualized by laser ﬂuoroscopy as
described. Proteins preparations were of the expected size. (B) Micrococal nuclease
digests of a representative pG5MLT reconstituted chromatin template shows the
expected regularly spaced nucleosome pattern. Lanes 1 and 2 are 150 ng of pG5MLT
reconstituted chromatin digested with 1.8 units of micrococcal nuclease for 3 and
9min respectively. Indicated sizes reﬂect the migration of a 100 bp DNA ladder.Results
Assembly of reconstituted chromatin
Reconstituted chromatin assembly described by Thomas and
Chiang (2005) requires puriﬁed HeLa core histones (CHs), Droso-
phila nucleosome assembly factor ACF which is assembled from
recombinant Acf1 and FLAG-tagged ISWI, recombinant human
nucleosome assembly protein-1 (NAP-1) histone chaperone and a
DNA template. For E1A transcription-repression analysis, chromatin
was assembled around the pG5MLT DNA template. This plasmid
has ﬁve Gal4 DNA binding sites upstream of the E1A repressible Ad
major-late core promoter which precedes a 380 bp G-less cassette.
The Gal4 DNA sites facilitate the binding of the Gal4-VP16 activator
used in these studies. The G-less cassette facilitates the measure-
ment of correctly initiated transcription from the template.
The assembly of in vitro reconstituted chromatin requires highly
puriﬁed components. Aliquots of pG5MLT puriﬁed by double CsCl
density gradient banding were analyzed by agarose gel electrophor-
esis (data not shown) and protein components puriﬁed as described
in Materials and methods were analyzed by SDS-PAGE and quantiﬁed
by SYPRO orange staining and laser ﬂuoroscopy. Fig. 1A shows SDS-
PAGE analysis of near homogeneous protein components used for
chromatin assembly and for in vitro transcription from reconstituted
chromatin. NAP-1 preparations show the expected 58 kDa band
with greater than 90% purity. The puriﬁed core histone preparation
shows the expected bands. The reconstituted ACF complex prepara-
tion shows the clean Acf1 band (200 kDa) and the FLAG-tagged
ISWI band (130 kDa). The major band of the p300 preparation is
the expected size. The Gal4-VP16 activator also runs at the expected
size (about 30 kDa).
The chromatin template was assembled as described (Thomas
and Chiang, 2005) but with pG5MLT as template. Assembled
chromatin was characterized on agarose gels after digestion with
micrococcal nuclease to assure that the expected regularly spaced
nucleosome pattern was formed (Fig. 1B). Analysis of micrococcal
nuclease digested chromatin preparations using a Gel Doc XR
imager (Bio Rad) running Quantity One software found that on
average, 94% of pG5MLT DNA was associated with nucleosomes.
Assembled chromatin was then used in in vitro transcription-
repression assays as described in Materials and methods.
Transcription from a reconstituted chromatin template is authentic
and is repressed by the E1A N-terminal repression domain
In order to facilitate analysis, transcription from reconstituted
chromatin was performed by step-wise addition of activator,p300/acetyl-CoA, nuclear extract and ribonucleoside tripho-
sphates (rNTPs). Transcription from a chromatin template can
conveniently be divided into several stages. The ﬁrst is the
recruitment of the potent Gal4-VP16 activator to the Gal4 DNA
binding sites of the chromatin pG5MLT promoter. The second
stage is activation where p300 and acetyl-CoA are added and are
recruited to the promoter-bound Gal4-VP16. During this step,
acetylation of the nucleosomal core histones on reconstituted
chromatin occurs. The third stage is the formation of a transcrip-
tion pre-initiation complex (PIC). PIC formation begins with the
addition of nuclear extract containing the general transcription
factors including TFIID as well as Mediator and Pol II complex. The
fourth stage is initiation of transcription which occurs upon the
addition of rNTPs.
In the experiments described in Fig. 2, the ﬁrst two stages
were combined into a single activation step in which the pG5MLT
reconstituted chromatin template was incubated with Gal4-VP16
activator, acetyl-CoA and p300 for 20 min. at 30 1C. The third
stage (PIC formation) was accomplished by the addition of
nuclear extract and incubation at 30 1C for an additional 20 min.
Fig. 2. Transcription from pG5MLT is p300 and acetyl-CoA dependent and is
repressed by E1A 243R and E1A 1–80 but not by E1A 1–80 D4–25. Lane 1 shows
transcription from naked DNA of both pG5MLT and pDMLP. Lanes 2 to 7 show
transcription from pG5MLT reconstituted chromatin and the naked DNA control
pDMLP. Components of chromatin transcription (Gal4-VP16, p300 and acetyl-CoA)
as well as E1A polypeptides were added as indicated. Radio-labeled transcripts
were visualized by phosphor-image analysis.
Fig. 3. Repression of transcription from a pG5MLT chromatin template (A) and a
naked DNA template (B) is repressible by E1A 1–80 in a similar dose-dependent
manner. Shown are transcripts from reactions containing increasing amounts of
E1A 1–80 (12.5 ng, 25 ng, 50 ng and 100 ng). Indicated below are the relative
amounts of transcription as determined by phosphor-image analysis.
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of rNTPs and incubation for 60 min at 30 1C.
Fig. 2, lane 1 shows in vitro transcription from two naked DNA
templates, pG5MLT DNA and pDMLP. pG5MLT DNA as reconsti-
tuted chromatin template is used in all other reactions. pDMLP is
added to all reactions as a naked DNA control at the initiation step
of transcription. pDMLP consists of the MLP core promoter alone
with a G-less cassette of 210 bp in order to distinguish it from the
transcript of the chromatin template of 380 bp (Wu and Chiang,
2001). Both naked DNA templates are efﬁciently transcribed in the
absence of Gal4-VP16 activator or added p300/acetyl-CoA (lane 1).
Fig. 2, lane 2 shows that the pG5MLT template in reconstituted
chromatin is silent in the absence of Gal4-VP16 activator, even in
the presence of p300 and acetyl-CoA. As expected, transcription
from the naked DNA control occurs in the absence of activator.
However, when Gal4-VP16 activator and p300/acetyl-CoA are
both present (lane 3), there is strong transcription from the
chromatin template; in the presence of p300/acetyl Co-A, multi-
ple transcription start sites within the naked pDML DNA become
more apparent and the authentic transcript is less distinct. Lane
4 shows transcription from a reaction containing the Gal4-VP16
activator but lacking p300/acetyl-CoA. In this case transcription
from the chromatin template is severely limited whereas tran-
scription from the naked DNA control is unaffected. These data
show that transcription from the pG5MLT reconstituted chroma-
tin template requires activation and is very largely p300/acetyl-
CoA dependent as is expected for reconstituted chromatin. The
small amount of transcription from pG5MLT occasionally seen in
lane 4 is likely due to endogenous p300 and acetyl-CoA present in
the nuclear extract (Thomas and Chiang, 2005).
We have shown in several studies that E1A 243R and E1A 1–80
efﬁciently inhibit transcription from several E1A repressible
naked DNA templates both by in vitro transcription and by DNA
transfection analysis. It is important to establish the ability of E1A
243R and the E1A repression domain alone to repress authentic
transcription from a reconstituted chromatin template. Therefore,
we tested the ability of E1A 243R and E1A 1–80 to block
transcription from the pG5MLT chromatin template when added
at the activation stage of chromatin transcription. When 125 ng of
E1A 243R is added to a reaction mixture that contains both an
activator and p300/acetyl-CoA, transcription from both chromatin
and naked DNA templates is inhibited (see lane 5). Of signiﬁcance,
when 125 ng of the E1A repression domain alone (E1A 1–80) is
added, transcription from both templates is also blocked (lane 6).
Taken together these data (Fig. 2) indicate that transcription from
the pG5MLT reconstituted chromatin template is authentic and is
repressible by E1A 243R and the E1A repression domain alone. As
shown in lane 7, this conclusion is further validated by the
inability of E1A 1-80D4-25, a mutant that is deﬁcient in the E1Arepression function (Loewenstein et al., 2006), to effect transcrip-
tion from either the chromatin or the naked DNA template.
Our previous studies using the naked DNA template pHIV LTR,
demonstrated that E1A 1–80 represses transcription in a dose-
dependent manner (Loewenstein et al., 2006). Similar dose
response transcription-repression assays were conducted to deter-
mine whether E1A 1–80 can repress transcription of a chromatin
template as efﬁciently as it does a naked DNA template. As shown
in Fig. 3, transcription from a pG5MLT chromatin template (Fig. 3A)
and from a pG5MLT naked DNA template (Fig. 3B) is repressed by
E1A 1–80 in a dose-dependent manner to approximately the same
degree. For example 100 ng of E1A 1–80 inhibits transcription from
pG5MLT as chromatin about 86% and inhibits transcription form
pG5MLT as naked DNA about 91%. In these experiments pG5MLT
as both chromatin and as naked DNA template are activated by
Gal4 VP-16 (See Materials and methods).
Order-of-addition analysis suggests new activities for the E1A
transcription-repression domain
In addition to disrupting the basal transcription machinery as E1A
does with naked DNA templates, it is entirely possible that the E1A
repression domain can also modulate transcription from chromatin
templates by other mechanisms. For instance, since transcription
from chromatin templates requires acetylation of nucleosomal his-
tones by p300, interference with this step during activation of the
chromatin template could result in the blockage of transcription.
In order to examine these possibilities, E1A 1–80 was added to
chromatin transcription reactions at various stages depicted in
Fig. 4A. E1A 1–80 at two levels was added to reactions (a) with the
chromatin template prior to activation and incubated at 271 for
30 min (pre-activation); (b) at the stage when the Gal4-VP16
activator and p300/acetyl-CoA are added to the chromatin template
(activation); (c) with the nuclear extract to the activated/acetylated
chromatin template (PIC formation); (d) when the ribonucleoside
triphosphates are added to the reaction (transcription initiation); and
(e) at 20 min after the beginning of transcription (early transcription).
As shown in Fig. 4B, when E1A 1–80 at 62.5 or 125 ng/reaction
is added with the pG5MLT chromatin template at the pre-
activation step, transcription-repression occurs in a dose-depen-
dent manner. A similar dose-dependent transcription-repression
occurs when E1A 1–80 is added at the beginning of the activation
stage. Surprisingly, when E1A 1–80 (62.5 ng/reaction) is added
immediately before nuclear extract during the PIC formation step,
transcription from the reconstituted chromatin template is not
repressed, but instead in stimulated greatly (about three-fold). Yet
when E1A 1–80 is added at even higher levels (250 ng/reaction)
the activated level of transcription is diminished about 50%. When
E1A 1–80 is added immediately before transcription-initiation,
Fig. 4. (A) Shown is a schematic of parallel in vitro transcription reactions using pG5MLT reconstituted chromatin as template in which two levels of E1A 1–80 (62.5 and
125 ng) were added at various stages. (B) Shown are transcripts from the reactions depicted above. The relative amounts of transcription are indicated. At pre-activation, strong,
dose-dependent repression of transcription from the pG5MLT chromatin template by E1A 1–80 is seen, an average of 49% of the control activity for 62.5 ng and 12% for 125 ng
of E1A 1–80 with a standard deviation (SD) of 6% and 9% respectively from 8 experiments. At activation, strong dose-dependent repression is also seen, an average of 56% of
control for 62.5 ng and 22% for 125 ng of E1A 1–80 with a SD of 8% and 9% respectively from 8 experiments. At PIC formation, signiﬁcantly enhanced activity is seenwhen of E1A
1–80 is added; 277% of control activity for 62.5 ng and 148% for 125 ng with a SD of 17% and 19% respectively from 5 experiments. At transcription-initiation, slightly enhanced
activity is again seen when 62.5 ng of E1A 1–80 is added; an average of 116% control activity with a SD of 27% from 5 experiments. However, when 125 ng of E1A 1–80 is added,
signiﬁcant repression is seen with an average of 37% of the control activity with a SD of 16% for 5 experiments. At early transcription, strong dose-dependent repression is again
seen, 72% of control activity for 62.5 ng and 41% with 125 ng of E1A 1–80 with an SD of 6% and 9% respectively from 8 experiments. (C) Shown is a parallel temporal analysis
using pG5MLT as naked DNA template. In all stages, E1A 1–80 represses transcription in a dose-dependent manner.
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higher levels of E1A 1–80 repress transcription signiﬁcantly (i.e.
over 5 fold from the activated level). Finally, when E1A 1–80 is
added at 20 min after initiation of transcription, transcription is
once again signiﬁcantly repressed in a dose-dependent manner.
These data described above reveal an intriguing complexity that
may be speciﬁc for the E1A transcription-repression domain in the
chromatin environment. To further test this possibility, comparable
experiments were carried out using Gal4 VP-16 activated naked
pG5MLT DNA as template. Fig. 4C shows that E1A 1–80 transcrip-
tion-repression occurs in a dose-dependent manner at the pre-
activation, activation, PIC formation, transcription initiation and early
transcription stages when added to naked DNA pG5MLT template
using the same temporal scheme as for pG5MLT chromatin template
(Fig. 4B). With pG5MLT as naked DNA template there is no stimula-
tion of transcription when E1A 1–80 is added immediately before
nuclear extract during the PIC formation stage or when low levels of
E1A 1–80 is added at the beginning of the transcription initiation
stage. This is in contrast to E1A 1–80 enhancement of transcription
from pG5MLT as reconstituted chromatin at the PIC formation and
transcription initiation stages (Fig. 4B).Discussion
The E1A transcription-repression domain can repress transcription
from a chromatin template
Transcription from silent chromatin templates requires activa-
tion by sequence speciﬁc activators and co-activators. Co-activa-
tors are generally divided into two groups: those that are involved
in chromatin remodeling and those that interact directly with the
general transcription factors and Pol II (Black et al., 2006).
Although chromatin remodeling factors and other transcription
factors needed to assemble a functional PIC are widely studied,
the ordered recruitment of these factors necessary to activate
chromatin transcription is incompletely understood. It would
not be surprising therefore that the mechanism by which E1A
represses transcription from chromatin, although intriguing, is
even more difﬁcult to elucidate.
Based on previous extensive mutational and functional analysis,
we have proposed a model for E1A repression. To restate brieﬂy: E1A
gains access to repressible promoters by interaction with cellular
partners such as p300 as molecular scaffolds and thereby contacts
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the data presented here that E1A 243R and the E1A repression
domain alone can repress transcription from a chromatin template
in vitro and does so in a dose-dependent manner and at about the
same level as from a naked DNA template (Figs. 2 and 3). However, it
is entirely possible that E1A modulates transcription from E1A
repressible chromatin promoters at multiple stages during transcrip-
tion. It is signiﬁcant that the E1A N-terminal repression domain
interacts with both p300 and with TFIID, members of both groups of
transcription factors needed for activation of a chromatin template
(Boyd et al., 2002; Loewenstein et al., 2006). Further, the E1A
transcription-repression domain is known to interact with several
HATs in addition to p300 that could also play a role in E1A
repression. For instance, the E1A N-terminus can interact with PCAF,
hGCN5, TRRAP, p400 and Tip60 (reviewed in Frisch and Mymryk,
2002). This suggests that E1A could possibly modulate chromatin
remodeling needed for transcription from chromatin templates as
well as interfere with the basal transcription machinery.
As a ﬁrst attempt to investigate the possibility of multiple
mechanisms of repression, we added E1A 1–80 at various stages of
transcription from chromatin (Fig. 4). E1A 1–80, when added at the
pre-activation step in the presence of only the reconstituted chroma-
tin template and various buffers (no activator, p300 or acetyl-CoA),
efﬁciently inhibits transcription. It seems unlikely that E1A 1–80, by
itself, alters the nature of chromatin to prevent transcription. It seems
more likely that E1A 1–80 is sufﬁciently stable to interfere with
transcription at stages after pre-activation. E1A 1–80 also efﬁciently
inhibits transcription from the chromatin promoter when added at
the activation step where chromatin, Gal4-VP16 activator, p300 and
acetyl-CoA are present. Again it is possible that E1A 1–80 does not
modulate transcription at this step, but at a later step. However, from
these data, we do not exclude the distinct possibility that the E1A
repression domain can alter normal acetylation of nucleosomal
histones through its interaction with p300. For example, E1A 243R
has been reported to inhibit p300 HAT activity, but this activity does
not require E1A N-terminal sequences and thus its relevance to E1A
repression is unclear (Chakravarti et al., 1999; Hamamori et al. 1999).
Of interest, E1A 243R can be acetylated by p300 which appears to
regulate binding of the co-repressor CtBP to E1A CR4 (Zhang et al.,
2000). Of particular interest, the human papillomavirus E6 oncopro-
tein inhibits the acetylation of both p53 and nucleosomal histones to
repress p53-dependent transcription from a chromatin template
(Thomas and Chiang, 2005).
Is an E1A N-terminal activation function revealed by temporal
analysis of transcription from a chromatin template?
An unanticipated ﬁnding was that E1A-1–80 (62.5 ng) stimu-
lates transcription about three fold when added with the nuclear
extract at the PIC formation step of a chromatin transcription
reaction whereas higher levels (125 ng) resulted in a reduced
stimulation (about 50%). When E1A 1–80 (62.5 ng) is added at the
end of the PIC formation but just prior to transcription-initiation,
transcription is again stimulated but higher levels of E1A 1–80
(125 ng) clearly repress transcription. These phenomena appear
to reﬂect the chromatin nature of the DNA template since
transcription from a naked pG5MLT DNA template in analogous
reactions is efﬁciently repressed rather that activated. Finally,
when E1A 1–80 is added after transcription initiation of chroma-
tin templates (early transcription), repression occurs at both
levels as it does when added at the pre-activation and activation
stages consistent with our model that E1A disrupts the basal
transcription machinery at the PIC level.
Some studies have described an activation activity for E1A
243R. Several cellular genes that possess E2F DNA binding sites
have been shown to be activated by E1A relief from repression bydisrupting Rb-family-E2F complexes; however, E1A sequences
required for this function are included within CR2, which is
dispensable for E1A repression (Berk, 2007). The activation
activity seen for E1A 1–80 in the temporal assay (Fig. 4B) is
therefore not likely due to this pathway. However, other gene
promoters may be activated by sequences found within E1A 1–80.
For example hsp70 has been reported to be activated by
sequences within the E1A repression domain by a mechanism
which involves the disruption of binding of the Dr1 transcrip-
tional repressor to the TATA sequence by E1A (Kraus et al., 1994).
However, it seems unlikely that this mechanism is responsible for
the activation seen in this temporal assay.
It seems more reasonable that the dual transcription activity of
the E1A N-terminus seen in the temporal assay with a chromatin
template (Fig. 4B) reﬂects its interaction with its major cellular
partner’s p300 and TFIID. In this context, it is of considerable
interest that in a reconstituted chromatin transcription system,
Mediator facilitates PIC formation by interacting ﬁrst with p300
and then recruiting TFIID to the nascent PIC as p300 autoacety-
lates and falls from the complex (Black et al., 2006). It may be that
E1A 1–80 mimics the role of Mediator in activating transcription
from chromatin templates. It is interesting that when E1A 1–80 is
added to a chromatin transcription reaction at the pre-PIC and PIC
formation stages, it can stimulate transcription but that this
stimulation is in inversely proportional to the amount of E1A
1–80 present. This might suggest that E1A at these stages could
serve to recruit TFIID in the nuclear extract to the promoter
through the ability of E1A 1–80 to interact with both p300 (bound
to the Gal4-VP16 activator) and to TFIID. For example it has been
reported than artiﬁcial tethering of TBP to a promoter results in
transcriptional activation by assisting in PIC formation (He and
Weintraub, 1998). We speculate that when the levels of E1A 1–80
and PIC formation are both high, E1A can then disrupt PICs
resulting in transcription-repression as predicted by our model
of E1A repression.
We note one caveat. Although chromatin is the natural
template for the study of transcriptional activation and repres-
sion, any study which of necessity requires the temporal addition
of modulating factors introduces additional challenges of inter-
pretation. Within the cell nuclear environment, transcription
from chromatin takes place in the simultaneous presence of
template, sequence speciﬁc activators, co-activators including
p300, TFIID and Mediator, as well as general transcription factors.
Continued study will be required to sort out the details of
transcriptional modulation by the E1A repression domain and
its role in cell cycle regulation and virus replication.Materials and methods
Constituents of chromatin assembly and for activated transcription
from chromatin
All plasmids used were puriﬁed by double CsCl density gradient
centrifugation and analyzed by agarose gel electrophoresis. Plas-
mids expressing FLAG-tagged Nap1 (pF:hNAP1-11d) and a FLAG-
tagged Gal4 DNA binding domain fused to VP16, (pf:Gal4-VP16)
(Chiang and Roeder, 1995), were transfected into BL21-Lys bacter-
ial cells (Invitrogen). Bacterial cell pellets from IPTG-induced
cultures were harvested and subjected to anti-FLAG agarose
afﬁnity chromatography and elution with FLAG peptide (Sigma)
as previously described (Chiang and Roeder, 1993). Baculovirus
vector stocks expressing Acf-1 and FLAG-tagged ISWI or FLAG-
tagged p300 (Thomas and Chiang, 2005) were used to serially
infect Sf-9 insect cells in order to produce sufﬁciently high titers to
infect liter quantities of Sf-9 cells. FLAG-tagged ACF complex and
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chromatography.
HeLa cell core histones were puriﬁed from 20 l of cells grown to a
density of 0.6106 cells/ml (National Cell Culture Center). A nuclear
transcription extract was ﬁrst extracted from the HeLa cell nuclei
(Dignam et al., 1983). The pellet remaining after extraction was then
suspended by Dounce homogenization using an A pestle (Kontes) in
50ml HB buffer (20 mM Tris pH 7.5, 1 mM EDTA, 10% glycerol,
400 mM NaCl, 1 mM b-mercaptoethanol, 0.5 mM PMSF, 2 mg/ml
pepstatin A, 2 mg/ml leupeptin and 5 mg/ml aprotinin). The nuclei
were centrifuged again, resuspended and washed twice in 50 ml of
the same buffer containing 0.2% NP-40. The pellet was washed twice
in 50 ml of HAP buffer (50 mM Na2PO4 pH 6.8, 1 mM b-mercap-
toethanol, 0.5 mM PMSF, 2 mg/ml pepstatin A, 2 mg/ml leupeptin and
5 mg/ml aprotinin) containing 400mM NaCl. The pellet was then
suspended in 40ml of HAP buffer containing 600mM NaCl and
subjected to sonication until the average DNA fragment size was
about 1.5 kb as determined by agarose gel electrophoresis of
proteinase K treated aliquots. The sonicated nuclear preparation
was added to 15 ml (bed volume) of hydroxylapatite resin (Bio Gel
HTP—BioRad) and rotated overnight at 4 1C in a 50ml centrifuge
tube. The resin was washed with 5 volumes of the HAP buffer. Core
histones were eluted batch-wise from the resin in 2 volumes of HAP
buffer containing 2.5 M NaCl and subjected to dialysis against
10 mM HEPES pH 7.9, 1 mM EDTA, 10 mM KCl, 10% glycerol,
0.5 mM PMSF, and 1mM dithiothreitol.
All of the puriﬁed proteins needed for the ordered assembly of
chromatin and activated transcription were subjected to SDS-
PAGE, staining with SYPRO orange followed by analysis and
quantiﬁcation by laser ﬂuoroscopy using a Typhoon Trio scanner
(GE Health Sciences).Chromatin assembly and chromatin transcription-repression assays
Chromatin assembly using pG5MLT as template was performed
and aliquots of assembled chromatin were subjected to analysis
by digestion with micrococcal nuclease and agarose gel electro-
phoresis as described (Thomas and Chiang, 2005). Chromatin
transcription reactions were conducted as described (Thomas
and Chiang, 2005) except that E1A 243R, E1A 1-80D4-25 or E1A
1–80 polypeptides, produced and puriﬁed as described (Boyd
et al., 2002), were added at various times during the reaction.
Radio-labeled transcripts from the G-less cassette of the pG5MLT
or pDMLP templates was analyzed as described (Thomas and
Chiang, 2005) and resolved by electrophoresis on 6% polyacryla-
mide gels containing 6 M urea. Transcription-repression reactions
from a pG5MLT naked DNA template were conducted as described
except that there was no added p300/Acetyl-CoA and that tran-
scription was activated by the addition of 14 ng of Gal4 VP-16.
Dried gels were exposed for 12 h to phosphor-storage screens and
transcripts visualized and quantiﬁed on a Typhoon Trio scanner
running ImageQuant software (GE Health Sciences).Acknowledgments
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